Investigational Site Number :7520003

Helsingborg 252 20

0 studies enrolling now · 2 studies all time

What they study most

Plasma Cell Myeloma, Type 2 Diabetes Mellitus

Studies at this site

• Isatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple Myeloma — Running, not enrolling
• Effect of Efpeglenatide on Cardiovascular Outcomes — Stopped early